Molecular dynamic analysis of SARS-CoV-2 inhibitors As of July 13, 2021, the coronavirus disease 2019 (COVID-19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected over 187 million people and caused the deaths of over 4 million people worldwide. Upon infection by SARS-CoV-2, this virus binds with high affinity to the human angiotensin converting enzyme-2 (ACE2) receptor present on the surface of human cells. This mechanism has therefore been of interest to many researchers looking to develop treatments that could block ACE2 and/or disable the spike (S) protein of SARS-CoV-2. A new study reports the results of molecular dynamic simulations that were performed in an effort to identify new drugs that could be effective against SARS-CoV-2.